Search results
2 Incredible Growth Stocks That Are Screaming Buys for 2024
Motley Fool via Yahoo Finance· 4 months agoThe new year is here, and for many, it's a fresh opportunity to set financial goals and find fresh...
Is Pfizer Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 3 months agoThe stock market is at record levels these days, but one company that isn't reflecting that optimism is Pfizer (NYSE: PFE). Shares of the pharma giant...
15 Best Drug Stocks to Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 15 best drug stocks to buy now. If you want to read about some more stocks, go to 5 Best Drug Stocks to Buy Now....
3 No-Brainer Stocks to Buy With $20 Right Now
Motley Fool via Yahoo Finance· 5 months agoOver multiple decades, Wall Street is nothing short of a bona fide wealth creator. But when examined over shorter timelines, it can be highly...
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Motley Fool· 9 months agoRegeneron Pharmaceuticals (NASDAQ: REGN) is a leader in the field of therapeutic proteins, with a...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 4 weeks agoIf Soranus of Ephesus were alive today he'd be mighty surprised. Like his modern-day counterparts in...
Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024
Investor's Business Daily· 5 months agoPharma and biotech stocks, led by Eli Lilly, Biogen and Crispr, are setting up for significant gains...
20 States with the Cheapest Weed in America
Insider Monkey via Yahoo Finance· 2 months agoIn this article, we are going to discuss the 20 states with the cheapest weed in America. You can skip our detailed analysis of the cannabis industry in...
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
Motley Fool· 6 months agoPfizer's (NYSE: PFE) stock performance has been disappointing this year (down 38%). For example,...
Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval
GuruFocus.com via Yahoo Finance· 6 months agoThe gene editing sector experienced a significant shakeup as CRISPR Therapeutics (NASDAQ:CRSP) and...